DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 34 filers reported holding DEXCOM INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,651,924 | +7123.6% | 12,694,000 | +6443.3% | 6.58% | +5992.6% |
| Q1 2023 | $548,923 | +82.6% | 194,000 | +78.0% | 0.11% | +129.8% |
| Q4 2022 | $300,690 | +103.2% | 109,000 | +45.3% | 0.05% | +80.8% |
| Q3 2022 | $148,000 | +13.0% | 75,000 | +5.6% | 0.03% | -10.3% |
| Q2 2022 | $131,000 | -84.4% | 71,000 | -73.7% | 0.03% | +625.0% |
| Q1 2022 | $842,000 | -92.5% | 270,000 | -92.0% | 0.00% | -99.8% |
| Q3 2021 | $11,157,000 | +28.2% | 3,355,000 | +0.4% | 1.81% | +7.2% |
| Q2 2021 | $8,700,000 | +36.9% | 3,341,000 | +16.3% | 1.69% | -20.1% |
| Q1 2021 | $6,354,000 | +11.4% | 2,873,000 | +14.7% | 2.11% | +50.9% |
| Q4 2020 | $5,703,000 | – | 2,504,000 | – | 1.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |